Trabectedin - EVER Pharma

Dosage Form	Powder for concentrate for solution for infusion
Strength	0.25 mg, 1 mg
Strength per Unit	0.25 mg, 1 mg
ATC Code	L01CX01
Drug Class	Antineoplastic agent
Indikation	Trabectedin EVER Pharma indicated for the treatment of adult patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. Efficacy data are based mainly on liposarcoma and leiomyosarcoma patients. Trabectedin EVER Pharma in combination with pegylated liposomal doxorubicin (PLD) is indicated for the treatment of patients with relapsed platinum-sensitive ovarian cancer.

Trabectedin EVER Pharma is a prescription medication. Information for healthcare professionals only.
See the Summary of Product Characteristics for full information about the medication.